首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1299篇
  免费   58篇
  国内免费   22篇
耳鼻咽喉   2篇
儿科学   48篇
妇产科学   8篇
基础医学   112篇
口腔科学   24篇
临床医学   107篇
内科学   399篇
皮肤病学   9篇
神经病学   18篇
特种医学   328篇
外科学   94篇
综合类   19篇
预防医学   51篇
眼科学   17篇
药学   126篇
中国医学   1篇
肿瘤学   16篇
  2021年   12篇
  2019年   7篇
  2018年   13篇
  2016年   10篇
  2015年   12篇
  2014年   12篇
  2013年   20篇
  2012年   14篇
  2011年   14篇
  2010年   27篇
  2009年   27篇
  2008年   25篇
  2007年   43篇
  2006年   45篇
  2005年   37篇
  2004年   34篇
  2003年   29篇
  2002年   46篇
  2001年   36篇
  2000年   28篇
  1999年   40篇
  1998年   49篇
  1997年   43篇
  1996年   63篇
  1995年   49篇
  1994年   38篇
  1993年   40篇
  1992年   23篇
  1991年   24篇
  1990年   23篇
  1989年   50篇
  1988年   57篇
  1987年   43篇
  1986年   38篇
  1985年   44篇
  1984年   29篇
  1983年   33篇
  1982年   31篇
  1981年   27篇
  1980年   15篇
  1979年   12篇
  1978年   8篇
  1977年   31篇
  1976年   22篇
  1975年   16篇
  1973年   4篇
  1972年   5篇
  1971年   4篇
  1970年   4篇
  1968年   4篇
排序方式: 共有1379条查询结果,搜索用时 296 毫秒
101.
Cefpirome serum concentrations were measured by microbiological assay in 30 patients after five to nine days of treatment with 1 or 2 g bd for moderate to severe infection of presumed bacterial origin. Patients with serum creatinine (SCr) greater than 220 mumol/L were excluded. The age of patients ranged from 34-86 years. Creatinine clearance (Clcr) was calculated from age, sex, weight and SCr. The range of SCr was 63-220 mumol/L and the range of Clcr was 18-169 mL/min. The correlation coefficient with cefpirome clearance was 0.464 for SCr and 0.747 for Clcr. More than half of the patients with Clcr less than 50 mL/min had SCr within the normal range of 70-150 mumol/L. Mean cefpirome clearance in patients with Clcr 18-50 mL/min was 42.7 mL/min, which is very similar to the figure of 43.5 mL/min reported in a single dose volunteer study in patients with renal failure. Mean cefpirome clearance in patients with Clcr greater than 80 mL/min was 107.6 mL/min. In conclusion, these data on cefpirome clearance obtained after multiple dose treatment of patients with presumed bacterial infection are consistent with data previously obtained from single dose volunteer studies and support the currently recommended dose regimens. Clinicians should take account of age, weight and sex when estimating renal function from SCr.  相似文献   
102.
103.
Stimulation of swine carotid artery medial fibers with 110 mM KCl at 37°C results in increases in myosin light chain (MLC) phosphorylation levels and maximal shortening velocity (V o) during the period of stress development. During the period of stress maintenance, MLC phosphorylation levels andV o are not maintained, but fall to suprabasal levels, resulting in a correlation between MLC phosphorylation andV o and suggesting that MLC phosphorylation regulatesV o. This study identifies other conditions of KCl depolarization of swine carotid medial fibers in which this relationship between MLC phosphorylation andV o is altered. A decrease in temperature from 37° to 23°C results in a similar magnitude of stress maintenance in response to 110 mM KCl and similar levels of MLC phosphorylation, but a reduction inV o by approximately 50%. This differential effect of temperature onV o and MLC phosphorylation results in a downward shift in the slope of the regression line describing the relationship between these two parameters. Decreasing [KCl] to 40 mM in the stimulating solution results again in similar magnitudes of miantained stress. MLC phosphorylation levels are not transient, but maintained at a constant value andV o is transient at levels approximately 50% of those at 110 mM KCl at 37°C. This results in a complete lack of correlation between MLC phosphorylation andV o. Thus stress can be developed to equal magnitudes under differing activation conditions with dissimilar patterns of MLC phosphorylation andV o. Therefore, there is not a strict relationship between MLC phosphorylation andV o in all cases.  相似文献   
104.
105.
106.
107.
Almost all primary retroperitoneal liposarcomas can be classified as well-/dedifferentiated liposarcoma. Rarely, however, primary retroperitoneal liposarcoma is classified as myxoid/round cell liposarcoma, based on the presence of myxoid areas and vascular crow's feet pattern, which has resulted in a debate on the classification of liposarcoma in the retroperitoneum. Genetically, myxoid/round cell liposarcoma and well-/dedifferentiated liposarcoma are different diseases. Myxoid/round cell liposarcoma is characterized by a translocation causing FUS-CHOP or EWSR1-CHOP fusion, whereas well-/dedifferentiated liposarcoma is characterized by an amplification of the 12q13-15 region, including MDM2 and CDK4 genes. As myxoid/round cell liposarcoma is highly radio- and chemosensitive, differentiation between subtypes is important to optimize treatment. We studied whether primary retroperitoneal liposarcomas diagnosed as myxoid/round cell liposarcoma represent molecularly true myxoid/round cell liposarcoma or are histopathological mimics and represent well-/dedifferentiated liposarcoma. Primary retroperitoneal myxoid/round cell liposarcoma (n=16) were compared to primary extremity myxoid/round cell liposarcoma (n=20). Histopathological and immunohistochemical features were studied. Amplification status of the 12q13-15 region was studied using a multiplex ligation-dependent probe amplification analysis, and FUS-CHOP or EWS-CHOP translocations were studied using RT-PCR. In primary retroperitoneal myxoid/round cell liposarcoma, MDM2 and CDK4 staining was both positive in 12 of 15 cases. In primary extremity myxoid/round cell liposarcoma, MDM2 was negative in 18/20 and CDK4 was negative in all cases. Multiplex ligation-dependent probe amplification showed the amplification of 12q13-15 region in 16/16 primary retroperitoneal myxoid/round cell liposarcomas and in 1/20 primary extremity myxoid/round cell liposarcomas. Translocation was present in all (18/18) primary extremity myxoid/round cell liposarcomas, but absent in all primary retroperitoneal myxoid/round cell liposarcomas. On the basis of immunohistochemical and molecular characteristics, apparent primary retroperitoneal myxoid/round cell liposarcoma can be recognized as well-/dedifferentiated liposarcoma with morphological features mimicking myxoid/round cell liposarcoma. In these cases, treatment should probably be specifically designed as for well-/dedifferentiated liposarcoma. Moreover, finding of myxoid/round cell liposarcoma translocations in a retroperitoneal localization is highly suggestive of metastasis and should prompt search for a primary localization outside the retroperitoneum.  相似文献   
108.
The claims made for 43 commercial filter ‘aids’, that they improve the colour discrimination of red‐green colour defectives, are assessed for protanomaly and deuteranomaly by changes in the colour spacing of traffic signals (European Standard EN 1836:2005) and of the Farnsworth D15 test. Spectral transmittances of the ‘aids’ are measured and tristimulus values with and without ‘aids’ are computed using cone fundamentals and the spectral power distributions of either the D15 chips illuminated by CIE Illuminant C or of traffic signals. Chromaticities (l,s) are presented in cone excitation diagrams for protanomaly and deuteranomaly in terms of the relative excitation of their long (L), medium (M) and short (S) wavelength‐sensitive cones. After correcting for non‐uniform colour spacing in these diagrams, standard deviations parallel to the l and s axes are computed and enhancement factors El and Es are derived as the ratio of ‘aided’ to ‘unaided’ standard deviations. Values of El for traffic signals with most ‘aids’ are <1 and many do not meet the European signal detection standard. A few ‘aids’ have expansive El factors but with inadequate utility: the largest being 1.2 for traffic signals and 1.3 for the D15 colours. Analyses, replicated for 19 ‘aids’ from one manufacturer using 658 Munsell colours inside the D15 locus, yield El factors within 1% of those found for the 16 D15 colours.  相似文献   
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号